In peripheral artery disease, which antiplatelet approach is recommended unless contraindicated?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

In peripheral artery disease, which antiplatelet approach is recommended unless contraindicated?

Explanation:
In peripheral artery disease, lowering the risk of heart attack, stroke, and limb-threatening events is achieved with single-agent antiplatelet therapy. Either aspirin or clopidogrel effectively reduces these vascular risks, and guidelines consider either option acceptable as long as there’s no contraindication. Using both agents routinely does not provide extra benefit in stable PAD and increases bleeding risk, so it isn’t the standard approach. If a patient cannot take one, the other serves as a suitable alternative, keeping the therapy effective while avoiding the specific intolerance.

In peripheral artery disease, lowering the risk of heart attack, stroke, and limb-threatening events is achieved with single-agent antiplatelet therapy. Either aspirin or clopidogrel effectively reduces these vascular risks, and guidelines consider either option acceptable as long as there’s no contraindication. Using both agents routinely does not provide extra benefit in stable PAD and increases bleeding risk, so it isn’t the standard approach. If a patient cannot take one, the other serves as a suitable alternative, keeping the therapy effective while avoiding the specific intolerance.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy